Sigachi Industries credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
13613614214340.5
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
11011070.186.07.7
0.26×0.26×0.23×0.32×0.15×
0.21×0.21×0.11×0.19×0.03×
2.52×2.52×1.42×1.87×0.69×
2.37×2.04×0.70×1.12×0.13×
2.60×2.60×6.78×8.48×12.14×
20.4%20.4%18.8%24.5%13.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SIGACHI₹26.60

Sigachi Industries Limited

· Pharma & Health
₹ CrorePeersLINCOLNTHEMISMEDBAJAJHCAREAMRUTANJANJAGSNPHARMWANBURYNGLFINEMcap ₹1,016 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt40.5143.1142.2135.6135.6
Net Debt7.786.070.1109.5109.5
Total Debt/Equity0.150.320.230.260.26
Net Debt/Equity0.030.190.110.210.21
Total Debt/EBITDA0.691.871.422.522.52
Net Debt/EBITDA0.131.120.702.042.37
Interest Coverage (EBIT/Interest)12.148.486.782.602.60
Total Debt/Total Capital %13.1124.4918.8220.4020.40
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.